Loading
Latest filing published 11 Mar 2026 for 비보존 제약, €1,371. Read the official filing
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
All filings by 박재심 on record concern 비보존 제약, in the capacity of chief executive. The record holds 3 filings, for trades running from 30 January 2026 to 5 March 2026.
On the market, this insider has only ever bought: 3 purchases, €1,371 in total. No amount is published for 2 filings, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The newest entry dates from 11 March 2026: an open-market purchase of €1,371, in 비보존 제약. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations